Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Poster: AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML
  1. Home
  2. Publications
  3. Poster: AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML

Poster: AML-407: Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes Even in Patients with NPM1 Mutated ELN Favorable Risk AML

Authors:
  • OCOnyee Chan
    Onyee Chan
  • NANajla Al Ali
    Najla Al Ali
  • SYSeongseok Yun
    Seongseok Yun
  • CTChetasi Talati
    Chetasi Talati
  • AKAndrew Kuykendall
    Andrew Kuykendall
  • EPEric Padron
    Eric Padron
  • DSDavid Sallman
    David Sallman
  • KSKendra Sweet
    Kendra Sweet
  • RKRami Komrokji
    Rami Komrokji
  • JLJeffrey Lancet
    Jeffrey Lancet

Publisher website
Google Scholar
  • 1 September 2021
    • journal article
    • abstracts
    • Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
    • Vol. 21, S214
    • DOI:10.1016/s2152-2650(21)01345-8
Abstract
No abstract available
Keywords
  • NPM1
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.